BioSpace News Archive

As Life Time, the nation’s premier healthy lifestyle brand, continues to add to its health and wellness portfolio and high-end athletic lifestyle resorts, the company today announced the opening of Life Time Work West End, the first-of-its-kind in Minnesota—and second in the country (Life Time Work Ardmore opened in April 2018.)

Happy Family Organics®, the largest organic baby food brand in the U.S.1, announced today that they have gained approval in three additional states to make their Happy Baby® Clearly Crafted™ Jars available to families participating in The Special Supplemental Nutrition Program for Women, Infants and Children (WIC).

MedeAnalytics, a leader in healthcare analytics, today announced the appointment of Melissa Green Dexter to its executive leadership team as vice president of human resources

The Biotechnology Innovation Organization (BIO) today announced Senator Pat Roberts (R-KS) will be presented with a Lifetime Achievement Award

KLAS Research, a healthcare IT data and insights company, recently interviewed healthcare facilities about their infection control initiatives, with a focus on innovative technologies (UV disinfection equipment, electronic hand-hygiene monitoring, and infection control software).

We’ve long recognized that compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product

Principal and CEO of The Surgicalist Group (TSG) Mit Desai, MD FACS announced today Dr. Casey J. Thomas, DO, FACS, FACOS, will serve as the new Chief Medical Officer for TSG.

Cato Research, LLC (CATO), a global provider of regulatory and clinical research services, announced today that its board of directors has appointed Mark Goldberg, M.D. to executive chairman, effective immediately

Kindbody, a new women’s healthcare company, announces a new program to enable self-insured employers to purchase fertility benefits direct

ADAM sets new milestone in medical technology by launching the 3D bioprinting of organic bone structures. ADAM has started passing the regulatory requirements to begin preclinical trials this month.